BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nisha R, Kumar P, Kumar U, Mishra N, Maurya P, Singh S, Singh P, Guleria A, Saha S, Saraf SA. Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma. Mol Pharm 2021;18:1102-20. [PMID: 33356314 DOI: 10.1021/acs.molpharmaceut.0c01024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Singh P, Alka, Maurya P, Nisha R, Singh N, Parashar P, Mishra N, Pal RR, Saraf SA. QbD Assisted Development of Lipidic Nanocapsules for Antiestrogenic Activity of Exemestane in Breast Cancer. J Liposome Res 2022;:1-43. [PMID: 35930249 DOI: 10.1080/08982104.2022.2108441] [Reference Citation Analysis]
2 Singh P, Singh N, Mishra N, Nisha R, Alka, Maurya P, Pal RR, Singh S, Saraf SA. Functionalized Bosutinib Liposomes for Target Specific Delivery in management of Estrogen-Positive Cancer. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112763] [Reference Citation Analysis]
3 Chavda VP, Dawre S, Pandya A, Vora LK, Modh DH, Shah V, Dave DJ, Patravale V. Lyotropic liquid crystals for parenteral drug delivery. J Control Release 2022;349:533-49. [PMID: 35792188 DOI: 10.1016/j.jconrel.2022.06.062] [Reference Citation Analysis]
4 Shan X, Luo L, Yu Z, You J. Recent advances in versatile inverse lyotropic liquid crystals. J Control Release 2022;348:1-21. [PMID: 35636617 DOI: 10.1016/j.jconrel.2022.05.036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Foglizzo V, Marchiò S. Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers (Basel) 2022;14:2473. [PMID: 35626078 DOI: 10.3390/cancers14102473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nisha R, Kumar P, Kumar U, Mishra N, Maurya P, Singh P, Tabassum H, Alka, Singh S, Guleria A, Saraf SA. Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121848] [Reference Citation Analysis]
7 Borase HP, Borkar MR, Chaturvedi KK, Kar Mahapatra D, Chalikwar SS, Dangre PV. Design and evaluation of natural deep eutectic solvents system for chrysin to elicit its solubility, stability, and bioactivity. Journal of Molecular Liquids 2022;345:118205. [DOI: 10.1016/j.molliq.2021.118205] [Reference Citation Analysis]
8 Maurya P, Saklani R, Singh S, Nisha R, Pal RR, Mishra N, Singh P, Kumar A, Chourasia MK, Saraf SA. Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophages. Drug Deliv Transl Res 2021. [PMID: 34476764 DOI: 10.1007/s13346-021-01055-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Zhang X, Wu W. Liquid Crystalline Phases for Enhancement of Oral Bioavailability. AAPS PharmSciTech 2021;22:81. [PMID: 33619612 DOI: 10.1208/s12249-021-01951-w] [Reference Citation Analysis]